Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,470
Closed -$769K 589
2023
Q4
$769K Buy
4,470
+1,338
+43% +$206K 0.25% 123
2023
Q3
$463K Sell
3,132
-10,699
-77% -$1.93M 0.33% 104
2023
Q2
$3.02M Buy
13,831
+8,191
+145% +$1.83M 0.52% 43
2023
Q1
$1.24M Buy
5,640
+1,721
+44% +$373K 0.23% 160
2022
Q4
$816K Buy
+3,919
New +$861K 0.15% 205
2022
Q3
Sell
-12,042
Closed -$2.52M 574
2022
Q2
$2.52M Buy
+12,042
New +$2.56M 0.57% 53
2021
Q2
Sell
-3,644
Closed -$707K 516
2021
Q1
$707K Buy
+3,644
New +$731K 0.08% 315
2020
Q3
Sell
-11,673
Closed -$2.24M 623
2020
Q2
$2.24M Buy
11,673
+3,535
+43% +$578K 0.35% 81
2020
Q1
$1.2M Buy
+8,138
New +$1.3M 0.44% 57
2019
Q3
Sell
-3,016
Closed -$368K 639
2019
Q2
$368K Buy
3,016
+529
+21% +$58.6K 0.03% 423
2019
Q1
$259K Sell
2,487
-3,182
-56% -$328K 0.02% 459
2018
Q4
$646K Buy
+5,669
New +$607K 0.09% 297
2018
Q3
Sell
-8,009
Closed -$830K 603
2018
Q2
$830K Buy
+8,009
New +$810K 0.17% 180
2015
Q4
Sell
-7,307
Closed -$373K 629
2015
Q3
$373K Buy
+7,307
New +$393K 0.05% 396
2015
Q1
Sell
-5,125
Closed -$287K 564
2014
Q4
$287K Buy
+5,125
New +$268K 0.07% 336

Other funds holding RMD

Cipher Capital's RMD Position: Q1 2024 in Review

Cipher Capital sold out of ResMed (RMD) in Q1 2024, closing a stake of 4,470 shares — an estimated $769K sold.

Cipher Capital first reported a position in RMD in Q4 2014 and held it in 15 quarters. The position peaked at $3.02M in Q2 2023. 719 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Cipher Capital reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
  • Cipher Capital sold 4,470 ResMed shares in Q1 2024, an estimated $769K.
  • Cipher Capital first reported a position in ResMed in Q4 2014 and held it in 15 quarters.
  • Cipher Capital's ResMed position peaked at $3.02M in Q2 2023.
  • 719 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.